rrd329023_371906.html

0001181431-13-002636.txt : 20130109 0001181431-13-002636.hdr.sgml : 20130109 20130109154154 ACCESSION NUMBER: 0001181431-13-002636 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130107 FILED AS OF DATE: 20130109 DATE AS OF CHANGE: 20130109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meeker David P CENTRAL INDEX KEY: 0001385155 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15313 FILM NUMBER: 13520559 MAIL ADDRESS: STREET 1: C/O PENWEST PHARMACEUTICALS CO STREET 2: 39 OLD RIDGEBURY ROAD SUITE 11 CITY: DANBURY STATE: CT ZIP: 06810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 3 1 rrd366430.xml X0206 3 2013-01-07 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001385155 Meeker David P 400 CROSSING BLVD BRIDGEWATER NJ 08807 1 0 0 0 Common Stock, $0.01 par value 12644.00 D Option to purchase Common Stock, $0.01 par value 1.17 2013-02-22 2023-01-07 Common Stock 16415.00 D The right to receive these shares is pursuant to a restricted stock grant that will vest as follows: 4308.00 February 22, 2013 and 8336.00 on the earlier of May 22, 2013 or the Company's 2013 Annual Meeting of Stockholders These stock options will vest as follows: 5593.00 on February 22, 2013 and 10822.00 on the earlier of May 22, 2013 or the Company's 2013 Annual Meeting of Stockholders. Philip K. Yachmetz 2013-01-09 EX-24. 2 rrd329023_371906.htm POA rrd329023_371906.html

POWER OF ATTORNEY
Know all by these present that the undersigned hereby constitutes and appoints Philip
K. Yachmetz and John C. Petrolino with full power of substitution, the undersigned's
true and lawful attorney-infact to:
(1)
execute for and on behalf of the undersigned, in the undersigned's capacity as an
officer and/or employee of Savient Pharmaceuticals, Inc. (the "Company"), Forms 3, 4,
and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the
rules thereunder;
(2)
do and perform any and all acts for and on behalf of the undersigned which may be
necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and
execute any amendment or amendments thereto, and timely file such form with the
United States Securities and Exchange Commission and any stock exchange or similar
authority; and
(3)
take any other action of any type whatsoever in connection with the foregoing which,
in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or
legally required by, the undersigned, it being understood that the documents executed
by such attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary, or
proper to be done in the exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as the undersigned might or could do if personally
present, with full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the rights and
powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-
fact, in serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the undersigned is no
longer
required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and
transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing
delivered to the foregoing attorneys-in-fact.
The undersigned hereby revokes and withdraws any previously executed powers of
attorney with
respect to the completion, execution and filing of Forms 3, 4 and 5 relating to the
undersigned's
holdings of and transactions in securities issued by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this.day of January, 2013.
David P. Meeker